News & Perspective

Oct 17, 2006

Oct 17, 2006

Baxter says cell-based H5N1 vaccine shows potential in trial

(CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.

Feb 03, 2006

Feb 03, 2006

Latest cases raise WHO's avian flu tally to 161

(CIDRAP News) – The World Health Organization (WHO) tally of human cases of H5N1 avian influenza rose to 161, including 86 deaths, with the final confirmation of 12 cases in Turkey and one in Iraq this week.